Aperio Group’s Core Laboratories CLB Stock Holding History

Aperio Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	$8.39M	Sell	316,366 -1,549	-0.5%	-$41.1K	0.02%	626
2020 Q3	$4.85M	Sell	317,915 -12,825	-4%	-$196K	0.02%	756
2020 Q2	$6.72M	Buy	330,740 +81,037	+32%	+$1.65M	0.02%	609
2020 Q1	$2.58M	Buy	249,703 +159,038	+175%	+$1.64M	0.01%	910
2019 Q4	$3.42M	Buy	90,665 +19,217	+27%	+$724K	0.01%	871
2019 Q3	$3.33M	Buy	71,448 +4,808	+7%	+$224K	0.01%	853
2019 Q2	$3.48M	Buy	66,640 +29,599	+80%	+$1.55M	0.01%	847
2019 Q1	$2.55M	Buy	37,041 +6,911	+23%	+$476K	0.01%	939
2018 Q4	$1.8M	Buy	30,130 +6,792	+29%	+$405K	0.01%	1034
2018 Q3	$2.7M	Buy	23,338 +1,268	+6%	+$147K	0.01%	897
2018 Q2	$2.79M	Buy	22,070 +2,144	+11%	+$271K	0.01%	868
2018 Q1	$2.16M	Buy	19,926 +63	+0.3%	+$6.82K	0.01%	968
2017 Q4	$2.18M	Buy	19,863 +8,923	+82%	+$978K	0.01%	955
2017 Q3	$1.08M	Buy	10,940 +5,058	+86%	+$499K	0.01%	1220
2017 Q2	$596K	Buy	5,882 +518	+10%	+$52.5K	﹤0.01%	1543
2017 Q1	$620K	Sell	5,364 -970	-15%	-$112K	﹤0.01%	1428
2016 Q4	$760K	Buy	6,334 +906	+17%	+$109K	0.01%	1266
2016 Q3	$610K	Sell	5,428 -1,235	-19%	-$139K	﹤0.01%	1341
2016 Q2	$825K	Buy	6,663 +482	+8%	+$59.7K	0.01%	1153
2016 Q1	$695K	Sell	6,181 -1,477	-19%	-$166K	0.01%	1208
2015 Q4	$833K	Buy	7,658 +1,240	+19%	+$135K	0.01%	1094
2015 Q3	$641K	Buy	6,418 +718	+13%	+$71.7K	0.01%	1171
2015 Q2	$650K	Sell	5,700 -495	-8%	-$56.4K	0.01%	1192
2015 Q1	$647K	Sell	6,195 -314	-5%	-$32.8K	0.01%	1137
2014 Q4	$783K	Buy	6,509 +1,940	+42%	+$233K	0.01%	1003
2014 Q3	$669K	Sell	4,569 -68	-1%	-$9.96K	0.01%	1008
2014 Q2	$775K	Sell	4,637 -177	-4%	-$29.6K	0.01%	942
2014 Q1	$955K	Buy	+4,814	New	+$955K	0.01%	1022
2013 Q4	–	Sell	-5,433	Closed	-$919K	–	912
2013 Q3	$919K	Sell	5,433 -214	-4%	-$36.2K	0.02%	873
2013 Q2	$856K	Buy	+5,647	New	+$856K	0.02%	825